Literature DB >> 34183772

DNAJA1 promotes cancer metastasis through interaction with mutant p53.

Atsushi Kaida1,2, Satomi Yamamoto1, Alejandro Parrales1,3, Eric D Young1, Atul Ranjan1,3, Mohamed A Alalem3, Kei-Ichi Morita4,5, Yu Oikawa6, Hiroyuki Harada6, Tohru Ikeda7, Sufi M Thomas8, Francisco J Diaz9, Tomoo Iwakuma10,11.   

Abstract

Accumulation of mutant p53 (mutp53) is crucial for its oncogenic gain of function activity. DNAJA1, a member of J-domain containing proteins or heat shock protein 40, is shown to prevent unfolded mutp53 from proteasomal degradation. However, the biological function of DNAJA1 remains largely unknown. Here we show that DNAJA1 promotes tumor metastasis by accumulating unfolded mutp53. Levels of DNAJA1 in head and neck squamous cell carcinoma (HNSCC) tissues were higher than those in normal tissues. Knockdown of DNAJA1 in HNSCC cell lines carrying unfolded mutp53 significantly decreased the levels of mutp53, filopodia/lamellipodia formation, migratory potential, and active forms of CDC42/RAC1, which were not observed in HNSCC cells with DNA contact mutp53, wild-type p53, or p53 null. Such mutp53-dependent functions of DNAJA1 were supported by the observation that DNAJA1 selectively bound to unfolded mutp53. Moreover, DNAJA1 knockdown in HNSCC cells carrying unfolded mutp53 inhibited primary tumor growth and metastases to the lymph nodes and lungs. Our study suggests that DNAJA1 promotes HNSCC metastasis mainly in a manner dependent on mutp53 status, suggesting DNAJA1 as a potential therapeutic target for HNSCC harboring unfolded mutp53.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34183772      PMCID: PMC8804903          DOI: 10.1038/s41388-021-01921-3

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

Review 1.  Chaperones and protein folding in the archaea.

Authors:  Andrew T Large; Martin D Goldberg; Peter A Lund
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

2.  Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia.

Authors:  C D Nobes; A Hall
Journal:  Cell       Date:  1995-04-07       Impact factor: 41.582

3.  Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.

Authors:  B Vojtesek; H Dolezalova; L Lauerova; M Svitakova; P Havlis; J Kovarik; C A Midgley; D P Lane
Journal:  Oncogene       Date:  1995-01-19       Impact factor: 9.867

Review 4.  Specification of Hsp70 function by Type I and Type II Hsp40.

Authors:  Douglas M Cyr; Carlos H Ramos
Journal:  Subcell Biochem       Date:  2015

5.  Overexpression of DNAJC12 predicts poor response to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.

Authors:  Hong-Lin He; Ying-En Lee; Hsin-Pao Chen; Chung-Hsi Hsing; I-Wei Chang; Yow-Ling Shiue; Sung-Wei Lee; Chao-Tien Hsu; Li-Ching Lin; Ting-Feng Wu; Chien-Feng Li
Journal:  Exp Mol Pathol       Date:  2015-03-21       Impact factor: 3.362

6.  DNAJC25 is downregulated in hepatocellular carcinoma and is a novel tumor suppressor gene.

Authors:  Tingting Liu; Wei Jiang; Dingding Han; Long Yu
Journal:  Oncol Lett       Date:  2012-09-10       Impact factor: 2.967

7.  YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.

Authors:  Masahide Sakabe; Jieqing Fan; Yoshinobu Odaka; Ning Liu; Aishlin Hassan; Xin Duan; Paige Stump; Luke Byerly; Megan Donaldson; Jiukuan Hao; Marcus Fruttiger; Qing Richard Lu; Yi Zheng; Richard A Lang; Mei Xin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

8.  Loss of Tid1/DNAJA3 Co-Chaperone Promotes Progression and Recurrence of Hepatocellular Carcinoma after Surgical Resection: A Novel Model to Stratify Risk of Recurrence.

Authors:  Kuan-Yang Chen; Yi-Hsiang Huang; Wan-Huai Teo; Ching-Wen Chang; Yu-Syuan Chen; Yi-Chen Yeh; Chieh-Ju Lee; Jeng-Fan Lo
Journal:  Cancers (Basel)       Date:  2021-01-04       Impact factor: 6.639

Review 9.  Mutant p53: One, No One, and One Hundred Thousand.

Authors:  Dawid Walerych; Kamil Lisek; Giannino Del Sal
Journal:  Front Oncol       Date:  2015-12-21       Impact factor: 6.244

Review 10.  Targeting Oncogenic Mutant p53 for Cancer Therapy.

Authors:  Alejandro Parrales; Tomoo Iwakuma
Journal:  Front Oncol       Date:  2015-12-21       Impact factor: 6.244

View more
  3 in total

1.  DNAJA1 Stabilizes EF1A1 to Promote Cell Proliferation and Metastasis of Liver Cancer Mediated by miR-205-5p.

Authors:  Lizhi Yi; Shunhui He; Zhengyu Cheng; Xi Chen; Xiaoli Ren; Yang Bai
Journal:  J Oncol       Date:  2022-05-09       Impact factor: 4.501

2.  Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin.

Authors:  Mohamed Alalem; Mrinalini Bhosale; Atul Ranjan; Satomi Yamamoto; Atsushi Kaida; Shigeto Nishikawa; Alejandro Parrales; Sana Farooki; Shrikant Anant; Subhash Padhye; Tomoo Iwakuma
Journal:  Cancers (Basel)       Date:  2022-08-29       Impact factor: 6.575

Review 3.  Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members.

Authors:  Atsushi Kaida; Tomoo Iwakuma
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.